Molecular Abnormalities in Ovarian Cancer Subtypes Other Than High-Grade Serous Carcinoma

Journal of Oncology - United States
doi 10.1155/2010/740968
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Hindawi Limited

Related search

Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

New in High Grade Serous Ovarian Cancer Treatment

Effective Pharmacotherapy
2019English

Integrated Analysis to Identify Molecular Biomarkers of High-Grade Serous Ovarian Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

High-Grade Serous Carcinoma Resulting From Rectal Endometriosis and Complicated With Ovarian Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

HMGA2: A Biomarker Significantly Overexpressed in High-Grade Ovarian Serous Carcinoma

Modern Pathology
Forensic MedicinePathology
2010English

Erratum To: Tubal Precursor Lesions in High Grade Serous Ovarian Carcinoma

Indian Journal of Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

PARP Inhibitors in Platinum-Sensitive High-Grade Serous Ovarian Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2018English

Amplification of the Ch19p13.2 NACC1 Locus in Ovarian High-Grade Serous Carcinoma

Modern Pathology
Forensic MedicinePathology
2011English

Characteristics of 10-Year Survivors of High-Grade Serous Ovarian Carcinoma

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy